Clinical trial
Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT04835597
Study timeline
Study start (actual)2022-08-15Date precision: day
Registry last updated2024-08-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Anatomic Stage I Breast Cancer AJCC v8unresolved
Anatomic Stage IA Breast Cancer AJCC v8unresolved
Anatomic Stage IB Breast Cancer AJCC v8unresolved
Anatomic Stage II Breast Cancer AJCC v8unresolved
Anatomic Stage IIA Breast Cancer AJCC v8unresolved
Anatomic Stage IIB Breast Cancer AJCC v8unresolved
Anatomic Stage III Breast Cancer AJCC v8unresolved
Prognostic Stage I Breast Cancer AJCC v8unresolved
Triple-Negative Breast Carcinomaunresolved
Interventions
Behavioral AssessmentBEHAVIORAL
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04835597 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.